Research map: Naringin sensitizes nasopharyngeal carcinoma cells to paclitaxel by inducing AKR1C3 expression

Back to the article

Papers in this map

  1. Nasopharyngeal carcinoma · Yu‐Pei Chen · 2019 · 3190 citations · Cited by this paper
  2. Association between oxidative balance score and gallstone risk and gallbladder surgery: A cross-sectional study · 2026 · Related
  3. The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma · Ling‐Long Tang · 2021 · 425 citations · Cited by this paper
  4. An adaptive attention U-network for recognizing ultrasound images · 2026 · Related
  5. Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials · Yu‐Pei Chen · 2018 · 166 citations · Cited by this paper
  6. Safety evaluation of bleomycin in ovarian cancer treatment: A pharmacovigilance analysis using Food and Drug Administration adverse event reporting system data · 2026 · Related
  7. Aldo-Keto Reductases and Cancer Drug Resistance · T.M. Penning · 2021 · 146 citations · Cited by this paper
  8. Platelet-to-albumin ratio and postoperative bleeding after endovascular treatment of intracranial aneurysms: A retrospective cohort study · 2026 · Related
  9. Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway · Hongzhong Li · 2013 · 129 citations · Cited by this paper
  10. Cross-sectional analysis of site- and ambient temperature–related variability in noncontact infrared thermometry among healthy Black African adults · 2026 · Related
  11. Anti-inflammatory and antioxidant activities of naringin isolated from Carissa carandas L.: In vitro and in vivo evidence · Ahmed H. El‐Desoky · 2018 · 105 citations · Cited by this paper
  12. Exploratory machine learning–based early post-treatment assessment of willingness to reuse rubber dam isolation after microscopic root canal treatment · 2026 · Related
  13. Naringin sensitizes human prostate cancer cells to paclitaxel therapy · Suat Erdoğan · 2017 · 79 citations · Cited by this paper
  14. Bilateral superselective adrenal artery embolization for primary aldosteronism: A comparative evaluation of clinical efficacy and safety · 2026 · Related
  15. Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: A pooled analysis of two randomised controlled trials · Melvin L.K. Chua · 2016 · 69 citations · Cited by this paper
  16. Association of high-sensitivity C-reactive protein-to-hemoglobin ratio with stroke risk: A study based on the China Health and Retirement Longitudinal Study and English Longitudinal Study of Ageing cohorts · 2026 · Related
  17. In vitro and in vivo characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3) · Aya Kikuchi · 2014 · 61 citations · Cited by this paper
  18. Probable linezolid-associated bilateral toxic optic neuropathy after prolonged therapy: A case report · 2026 · Related
  19. A novel ultradeformable liposomes of Naringin for anti-inflammatory therapy · María Pleguezuelos-Villa · 2017 · 58 citations · Cited by this paper
  20. Targeting bromodomain and extraterminal proteins in cardiovascular disease: Pathological mechanisms and therapeutic applications · 2026 · Related
  21. Naringin alleviates methotrexate-induced liver injury in male albino rats and enhances its antitumor efficacy in HepG2 cells · Hany Elsawy · 2020 · 51 citations · Cited by this paper
  22. Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV‐negative tumors is an indicator of poor prognosis · Christian Ulrich Huebbers · 2018 · 39 citations · Cited by this paper
  23. Naringin Induces Lysosomal Permeabilization and Autophagy Cell Death in AGS Gastric Cancer Cells · Suchismita Raha · 2020 · 35 citations · Cited by this paper
  24. AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma · Di Pan · 2022 · 35 citations · Cited by this paper
  25. Naringin suppresses the development of glioblastoma by inhibiting FAK activity · Jin-jiang Li · 2016 · 34 citations · Cited by this paper
  26. AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas · Marko Hojnik · 2020 · 27 citations · Cited by this paper
  27. AKR1C3 is a biomarker and druggable target for oropharyngeal tumors · Caterina Peraldo Neia · 2020 · 19 citations · Cited by this paper
  28. Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance · Toshiyuki Matsunaga · 2016 · 16 citations · Cited by this paper
  29. Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma · Jia Zheng · 2022 · 15 citations · Cited by this paper
  30. The prophylactic effects of naringin on steroid-induced early-stage osteonecrosis in rats: a preliminary study · Jian Zhuang · 2023 · 7 citations · Cited by this paper
  31. Chelidonine inhibits melanoma cell malignancy by inactivating TLR4/NF-κB and PI3K/AKT signaling pathways · Yu Zhou · 2025 · 3 citations · Cited by this paper
  32. Direct or indirect action mechanisms of Naringin in maintaining bone homeostasis · Xianghu Zhao · 2023 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)